On the news this morning is that one of the COVID-19 vaccine trials has been put on pause after a reported adverse reaction.
The Today Show was interviewing a medical expert this morning who explained what this means.
He said this is the process working as it should, and why we don't rush into approving a vaccine. They asked him what an adverse reaction likely was and if it meant something serious. And the expert says it was likely something like a autoimmune response or someone having a heart attack. What they need to do now is look at the data. Find out if the person in the trial had the vaccine candidate or the placebo. They wouldn't know that yet. Then they need to determine if the adverse reaction was related to the vaccine, or if it was something like a heart attack whether or not the person would have had a heart attack anyways without having the vaccine.
This will take them 3 days to a week to sort out. Because of the high profile nature of the vaccine they will likely make the results public. The experts believes vaccine trials will likely continue in a week or so.
The Today Show was interviewing a medical expert this morning who explained what this means.
He said this is the process working as it should, and why we don't rush into approving a vaccine. They asked him what an adverse reaction likely was and if it meant something serious. And the expert says it was likely something like a autoimmune response or someone having a heart attack. What they need to do now is look at the data. Find out if the person in the trial had the vaccine candidate or the placebo. They wouldn't know that yet. Then they need to determine if the adverse reaction was related to the vaccine, or if it was something like a heart attack whether or not the person would have had a heart attack anyways without having the vaccine.
This will take them 3 days to a week to sort out. Because of the high profile nature of the vaccine they will likely make the results public. The experts believes vaccine trials will likely continue in a week or so.